BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15277486)

  • 1. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
    Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates.
    Hare WA; Ton H; Ruiz G; Feldmann B; Wijono M; WoldeMussie E
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):127-36. PubMed ID: 11133857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey.
    Hare W; WoldeMussie E; Lai R; Ton H; Ruiz G; Feldmann B; Wijono M; Chun T; Wheeler L
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S284-9; discussion S295-6. PubMed ID: 11377450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological and histological measures of retinal injury in chronic ocular hypertensive monkeys.
    Hare W; Ton H; Woldemussie E; Ruiz G; Feldmann B; Wijono M
    Eur J Ophthalmol; 1999; 9 Suppl 1():S30-3. PubMed ID: 10230603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gradient of retinal functional changes during acute intraocular pressure elevation.
    Bui BV; Edmunds B; Cioffi GA; Fortune B
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):202-13. PubMed ID: 15623775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High infusion pressure in conjunction with vitreous surgery alters the morphology and function of the retina of rabbits.
    Minami M; Oku H; Okuno T; Fukuhara M; Ikeda T
    Acta Ophthalmol Scand; 2007 Sep; 85(6):633-9. PubMed ID: 17403020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of N-methyl-d-aspartate receptor 1 in rats with chronic ocular hypertension.
    Kim JH; Lee NY; Jung SW; Park CK
    Neuroscience; 2007 Nov; 149(4):908-16. PubMed ID: 17942238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia.
    Lagrèze WA; Knörle R; Bach M; Feuerstein TJ
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1063-6. PubMed ID: 9579489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine.
    Hare WA; Wheeler L
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2940-8. PubMed ID: 19136701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inner retinal dysfunction precedes ganglion cell loss in a mouse glaucoma model.
    Holcombe DJ; Lengefeld N; Gole GA; Barnett NL
    Br J Ophthalmol; 2008 May; 92(5):683-8. PubMed ID: 18296504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma.
    Yücel YH; Gupta N; Zhang Q; Mizisin AP; Kalichman MW; Weinreb RN
    Arch Ophthalmol; 2006 Feb; 124(2):217-25. PubMed ID: 16476892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evaluation of retina and optic nerve in the rat model of chronic ocular hypertension.
    Grozdanic SD; Kwon YH; Sakaguchi DS; Kardon RH; Sonea IM
    Exp Eye Res; 2004 Jul; 79(1):75-83. PubMed ID: 15183102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroretinogram and visual-evoked potential assessment of retinal and central visual function in a rat ocular hypertension model of glaucoma.
    Georgiou AL; Guo L; Francesca Cordeiro M; Salt TE
    Curr Eye Res; 2014 May; 39(5):472-86. PubMed ID: 24215221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage.
    Chauhan BC; Pan J; Archibald ML; LeVatte TL; Kelly ME; Tremblay F
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2969-76. PubMed ID: 12202517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
    Dreyer EB; Grosskreutz CL
    Clin Neurosci; 1997; 4(5):270-3. PubMed ID: 9292254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid.
    Moreno MC; Marcos HJ; Oscar Croxatto J; Sande PH; Campanelli J; Jaliffa CO; Benozzi J; Rosenstein RE
    Exp Eye Res; 2005 Jul; 81(1):71-80. PubMed ID: 15978257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.